XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating activities    
Net income $ 13,524 $ 24,257
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 266 290
Net amortization of investments 3,769 4,095
Deferred income taxes (13) 349
Net realized (gains) losses on investments 181 (248)
Net realized losses on disposal of assets 2 1
Share-based compensation 416 231
Changes in operating assets and liabilities:    
Premiums receivable, net (8,271) (11,821)
Accrued interest receivable (547) (804)
Deferred policy acquisition costs (566) 190
Amounts held by others   1,017
Other assets (1,148) (274)
Reserves for loss and loss adjustment expenses 6,720 4,145
Unearned premiums 1,775 1,870
Reinsurance balances 741 (1,306)
Amounts held for others and policyholder deposits 414 1,727
Accounts payable and other liabilities 6,531 6,615
Net cash provided by operating activities 23,794 30,334
Investing activities    
Purchases of investments held-to-maturity (53,640) (39,852)
Purchases of investments available-for-sale (34,081) (65,963)
Purchases of short-term investments (4,907) (5,576)
Proceeds from maturities of investments held-to-maturity 19,752 57,603
Proceeds from sales and maturities of investments available-for-sale 29,851 34,448
Proceeds from sales and maturities of short-term investments 1,630 1,508
Proceeds from redemption of other invested assets 2,000  
Purchases of property and equipment (73) (98)
Net cash used in investing activities (39,468) (17,930)
Financing activities    
Proceeds from stock option exercises   454
Tax benefit from share-based payments   435
Dividends to shareholders (3,909) (3,484)
Net cash used in financing activities (3,909) (2,595)
Change in cash and cash equivalents (19,583) 9,809
Cash and cash equivalents at beginning of period 58,936 69,481
Cash and cash equivalents at end of period $ 39,353 $ 79,290